Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

FCS unmasked: Closing gaps in diagnosis, treatment and patient support

Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics

Bridging diagnostic and therapeutic gaps in Fabry disease management

Applying patient and disease characteristics to guide R/M NPC treatment

Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes

Stargardt disease: Improving awareness, diagnosis and patient support

Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies

A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

HER2 as a targetable biomarker in gastrointestinal oncology

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease

Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025

Advancing care for patients with infantile haemangiomas: Timing is key

Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist

Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease

Applying immunotherapy in clinical practice for patients with early-stage NSCLC